Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,369 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,405)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01872403 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung | unknown | Phase 2 | 120 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 7, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's Hospital |
| 0 |
| Jun 5, 2013 |
| clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01830556 | Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck(CETMET) | unknown | Phase 2 | 120 | Karolinska University HospitalOTHER | 2 | May 21, 2013 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01821495 | Study of DC-CIK to Treat NPC | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01795768 | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours(FGFR) | unknown | Phase 2 | 48 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01333696 | Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT01739465 | Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 120 | Guangzhou Medical UniversityOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01796288 | The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment(ROLE) | unknown | Phase 2 | 200 | Wu Jieping Medical FoundationOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT01523015 | Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction | unknown | Phase 2 / Phase 3 | 100 | Medical University of LublinOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT01510990 | First Line Gefitinib by FDG-PET Metabolic Response | unknown | Phase 2 | 60 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01731548 | A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 500 | Zhejiang Cancer HospitalOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01760811 | CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT | unknown | Phase 1 / Phase 2 | 25 | Rabin Medical CenterOTHER | 1 | Jan 4, 2013 | clinicaltrials |
| NCT01755923 | Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01749072 | Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 120 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01746277 | Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC(PemSplitCisp) | unknown | Phase 2 | — | Universität Duisburg-EssenOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01218594 | Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer(DP-EN-RT) | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01688713 | Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01655628 | GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01573468 | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer(TESEGAST) | unknown | Phase 2 | 580 | Genta IncorporatedINDUSTRY | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01641783 | Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Yanqiao ZhangOTHER | 0 | Jul 17, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01641406 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"(NACprotocol) | unknown | Phase 2 | 60 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01215877 | Tesetaxel for Previously Treated Patients With Bladder Cancer | unknown | Phase 2 | 33 | Genta IncorporatedINDUSTRY | 2 | Jul 11, 2012 | clinicaltrials |
| NCT01635400 | Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01592422 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer | unknown | Phase 2 | 60 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01574729 | Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma(rAd-p53) | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01502202 | Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers | unknown | Phase 2 | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01614938 | Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer | unknown | Phase 2 | 46 | Fudan UniversityOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT01605734 | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 25, 2012 | clinicaltrials |
| NCT01556815 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | unknown | Phase 2 | 40 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01246817 | Temsirolimus-RCC-imaging | unknown | Phase 2 | 51 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01552980 | Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma(mSOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01394120 | Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Sofia Perea, Director Clinical Trials Unit.OTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 7, 2013source: clinicaltrials